Synthesis, spectral characterization, and in vitro antibacterial and antifungal activities of novel 1,3-thiazine-2-amines comprising morpholine nucleus

References

• Koketsu M, Tanaka K, Takenaka Y, Kwong CD, Ishihara H. Synthesis of 1,3-thiazine derivatives and their evaluation as potential antimycobacterial agents. Eur J Pharm Sci 2002;15:307–10.
   PubMed Web of Science ®Google Scholar
• Kai H, Morioka Y, Tomida M, Takahashi T, Hattori M, Hanasaki K, et al. 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds. Bioorg Med Chem Lett 2007;17:3925–9.
   PubMed Web of Science ®Google Scholar
• Kai H, Morioka Y, Murashi T, Morita K, Shinonome S, Nakazato H, et al. 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds. Bioorg Med Chem Lett 2007;17:4030–4.
   PubMed Web of Science ®Google Scholar
• Barros-García FJ, Bernalte-García A, Lozano-Vila AM, Luna-Giles F, Pariente JA, Pedrero-Marín R, et al. Synthesis, structural characterization and influence on the phagocytic activity of human neutrophils of thiazoline and thiazine derivative ligands and their zinc(II) complexes. J Inorg Biochem 2006; 100:1861–1870
   PubMed Web of Science ®Google Scholar
• Galanski ME, Erker T, Handler N, Lemmens-Gruber R, Kamyar M, Studenik CR. Studies on the chemistry of thienoanellated O,N- and S,N-containing heterocycles. Part 30: Synthesis and pharmacological properties of thieno[2,3-b][1,4]thiazines with potential vasopressin receptor antagonistic activity. Bioorg Med Chem 2006;14:826–36.
   PubMed Web of Science ®Google Scholar
• Malinka W, Kaczmarz M, Filipek B, Sapa J, Glod B. Preparation of novel derivatives of pyridothiazine-1,1-dioxide and their CNS and antioxidant properties. Farmaco 2002;57:737–46.
   PubMedGoogle Scholar
• Tozkoparan B, Aktay G, Yesilada E. Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and antiinflammatory activities. Farmaco 2002; 57:145–52.
   PubMedGoogle Scholar
• Loiseau PM, Mettey Y, Vierfond JM. Antifilarial and trypanocidal properties of phenothiazines and related polycyclics as new lead structures. Int J Parasitol 1996;26:1115–17.
   PubMed Web of Science ®Google Scholar
• Das J, Robl JA, Reid JA, Chong-Qing Sun, Misra RN, Brown BR, et al. Dual metalloprotease inhibitors. IV. Utilization of thiazepines and thiazines as constrained peptidomimetic surrogates in mercaptoacyl dipeptides. Bioorg Med Chem Lett 1994;4:2193–8.
   Web of Science ®Google Scholar
• Skiles JW, Suh JT, Williams BE, Menard PR, Barton JN, Love B, et al. Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity. J Med Chem 1986;29:784–96.
   PubMed Web of Science ®Google Scholar
• Manfred R, Michael M, Robert S, Wolfgang G. 1H and 13C NMR spectra of N-substituted morpholines. Eur Pat Appl (1989); EP 334146:28. Chem Abstr 1989;112:178999.
   Google Scholar
• Hale JJ, Mills SG, MacCross M, Dorn CP, Finke PE, Budhu RJ, et al. Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs. J Med Chem 2000;43:1234–7.
   PubMed Web of Science ®Google Scholar
• Fisher MH, Wyvratt MJ. Morpholine derivatives compositions and uses. US Patent (1991); 5077290:10. Chem Abstr 1991;116:214513.
   Google Scholar
• Avramova P, Danchev N, Buyukliev R, Bogoslovova T. Synthesis, toxicological, and pharmacological assessment of derivatives of 2-aryl-4-(3-arylpropyl)morpholines. Arch Pharm 1998;331:342–6.
   PubMed Web of Science ®Google Scholar
• Dorn CP, Hale JJ, MacCross M, Mills SG. Morpholine compounds are prodrugs useful as tachykinin receptor antagonists. US Patent (1997); 5691336:82. Chem Abstr 1997;128:48231.
   Google Scholar
• Varma RS, Prakash R, Khan MM, Ali A. 4-Phenyl morpholines as potent antimicrobial agents. Indian Drugs 1986;23:345–9.
   Google Scholar
• Misra VS, Singh S, Agarwal R, Chaudhary KC. Substituted morpholines derivatives as potent anti-inflammators. J Chem Soc Pak 1981;3:209–11
   Google Scholar
• Agarwal R, Chaudhary KC, Misra VS. Substituted morpholines compounds possessing central nervous system activities. J Chem Soc Pak 1984;6:308–10.
   Google Scholar
• Barret GC, Kane VV, Lowe G. Studies related to cephalosporin C. Part I. 3-Hydroxy- and 3-amino-furan-2(5H)-ones. J Chem Soc 1964:783–7.
   Web of Science ®Google Scholar
• Calaycay JR, Kelly TM, MacNaul KL, McCauley ED, Qi H, Grant SK, et al.Expression and immunoaffinity purification of human inducible nitric-oxide synthase. Inhibition studies with 2-amino-5,6-dihydro-4H-1,3-thiazine. J Biol Chem 1996;271:28212–19.
   PubMed Web of Science ®Google Scholar
• McCurnin DM, Bassert JM. Clinical Textbook for Veterinary Technicians, 5th ed. Philadelphia, PA: Saunders, 2002.
   Google Scholar
• Tandon VK, Maurya HK, Yadav DB, Tripathi A, Kumar M, Shukla PK. Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents. Bioorg Med Chem Lett 2006;16:5883–7.
   PubMed Web of Science ®Google Scholar
• Parks LW. Metabolism of sterols in yeast. CRC Crit Rev Microbiol 1978;6:301–41.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Sureshkumar P, Thanusu J, Kanagarajan V. Design, synthesis, characterization, antibacterial and antifungal activities of novel class of 5,7-diaryl-4,4-dimethyl-4,5,6,7-tetrahydropyridino[3,4-d]-1,2,3-selenadiazoles. J Enzyme Inhib Med Chem 2008;23:347–51.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Thanusu J, Kanagarajan V, Govindaraju R. Design, synthesis and in vitro microbiological evaluation of 6,6-dimethyl-7,9-diaryl-1,2,4,8-tetraazaspiro[4.5]decan-3-thiones – a new series of “tailor-made” compounds. J Enzyme Inhib Med Chem 2009;24:406–12.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Thanusu J, Kanagarajan V. Synthesis and biological evaluation of 5,7-diaryl-4,4-dimethyl-4,5,6,7-tetrahydropyridino[3,4-d]-1,2,3-thiadiazoles. Med Chem Res 2007;16:392–401.
   Web of Science ®Google Scholar
• Gopalakrishnan M, Sureshkumar P, Thanusu J, Kanagarajan V, Govindaraju R, Jayasri G. A convenient “one-pot” synthesis and in vitro microbiological evaluation of novel 2,7-diaryl-[1,4]-diazepan-5-ones. J Enzyme Inhib Med Chem 2007;22:709–15.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Sureshkumar P, Thanusu J, Kanagarajan V. Synthesis, spectral analysis, antibacterial and antifungal activities of some 4,6-diaryl-4,5-dihydro-3-hydroxy-2[H]-indazole – a novel fused indazole derivative. J Enzyme Inhib Med Chem 2008;23:974–9.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Sureshkumar P, Kanagarajan V, Thanusu J. Design, “one-pot” synthesis, characterization, antibacterial and antifungal activities of novel 6-aryl-1,2,4,5-tetrazinan-3-thiones in dry media. J Sulfur Chem 2007;28:383–92.
   Google Scholar
• Dhar MH, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of Indian plants biological activity. Part I. Indian J Exp Biol 1968;6:232–47.
   PubMed Web of Science ®Google Scholar